TED Ted Baker Plc

Tepnel Life Sciences PLC
29 May 2007


              Tepnel Life Sciences plc ('Tepnel' or 'the Company')

Allan Swift appointed by the British In Vitro Diagnostic Regulatory Association
              as Chairman of its Regulatory Affairs Working Group



Manchester, UK, 29 May 2007 Tepnel Life Sciences PLC (AIM: TED), the
international Molecular Diagnostics and Research Products & Services group
announces that Dr Allan Swift has been appointed by the British In Vitro
Diagnostic Regulatory Association (BIVDA) as Chairman of its Regulatory Affairs
Working Group.



BIVDA represents both manufacturers and distributors who are active in the UK,
irrespective of their origin.  BIVDA represents some of the largest and well
known diagnostic companies in the World.



The appointment began in March 2007. Allan Swift is Tepnel Life Sciences' Group
Regulatory Affairs Manager and ensures regulatory compliance of Tepnel's
products  and services with all quality and regulatory agencies worldwide.
Allan, a Ph.D scientist with over 80 publications, has been involved within
quality and regulatory issues within the in vitro diagnostic industry for 22
years, prior to that being the scheme administrator for the UK National External
Quality Assessment Schemes for Thyroid related hormones for the UK National
Health Service.  He is also a member of the UK National External Quality
Assurance Scheme for Molecular Genetics Steering committee and a registered
Laboratory Director with the New York State Department of Health



Allan will chair the quarterly meetings of the Regulatory Affairs Working Group
which consists of Regulatory Affairs professionals of all of the major UK and
International in vitro diagnostic manufacturers. Currently this is the largest
working group within BIVDA, with a regular attendance of 30 delegates and a
membership of 50 plus.



Ben Matzilevich, CEO of Tepnel commented:



"This is a very prestigious and visible appointment for Dr Allan Swift.
Diagnostics are a key part of Tepnel's business and Allan's in-depth experience
in regulatory affairs makes him the ideal Chairman of the Regulatory Working
Group at BIVDA. Having this interface with the UK and International regulatory
agencies puts Tepnel at the leading edge of opinion and decision makers within
the In vitro Diagnostic industry. In this new role, Allan will be at the
forefront of evolving regulatory issues and as Tepnel introduces increasingly
sophisticated in-vitro diagnostic products, such as QST*R, this knowledge will
be invaluable."



Doris-Ann Williams, Director General of BIVDA said:



 "Allan has been a key member of the Regulatory Affairs Group for many years and
we are delighted that he has agreed to become Chairman.  I'm looking forward to
working with Allan to ensure the IVD sector has input to any legislation
affecting the UK operations or impacting specifically on the IVD sector".





                                -          Ends-

For Further Information:



Tepnel Life Sciences plc

Ben Matzilevich, CEO

Carol Smith

Tel: 0161 946 2200



Capital MS&L

Mary Clark or Halina Kukula

Tel: +44 20 7307 5330

Email: mary.clark@capitalmsl.com



Notes to Editors

About Tepnel Life Sciences plc

Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees. TLS provides test kits,
reagents and services to two highly synergistic markets, these being Molecular
Diagnostics and Biomedical Research.  The company's strategy has been to
identify high growth niche opportunities within these multi-billion pound
markets. TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.





About The British In Vitro Diagnostics Association (BIVDA)

The British In Vitro Diagnostics Association (BIVDA) is the national trade
association for companies with major involvement and interest in the In Vitro
Diagnostics (IVD) industry. BIVDA represents both manufacturers and distributors
who are active in the UK. It is not just an association of UK diagnostic
companies, all IVD companies, irrespective of their national origin, are
eligible to become members of BIVDA. As well as providing regulatory support for
its members, BIVDA pursues a strategy of raising the awareness of the clinical
and cost utility of diagnostics in the provision of effective healthcare in the
UK. www.BIVDA.co.uk






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NRAAAMRTMMJTBLR

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024